nodes	percent_of_prediction	percent_of_DWPC	metapath
Thioridazine—CYP2C9—brain cancer	0.544	1	CbGaD
Thioridazine—CYP2D6—Lomustine—brain cancer	0.0509	0.255	CbGbCtD
Thioridazine—CYP1A2—Carmustine—brain cancer	0.0504	0.252	CbGbCtD
Thioridazine—CYP2D6—Hydroxyurea—brain cancer	0.0386	0.193	CbGbCtD
Thioridazine—CYP2E1—Etoposide—brain cancer	0.0258	0.129	CbGbCtD
Thioridazine—CYP2C8—Etoposide—brain cancer	0.0193	0.0965	CbGbCtD
Thioridazine—CYP1A2—Etoposide—brain cancer	0.0149	0.0747	CbGbCtD
Thioridazine—HTR2C—choroid plexus—brain cancer	0.00901	0.0801	CbGeAlD
Thioridazine—HTR2A—choroid plexus—brain cancer	0.00452	0.0402	CbGeAlD
Thioridazine—HRH1—nose—brain cancer	0.00349	0.031	CbGeAlD
Thioridazine—DRD1—telencephalic ventricle—brain cancer	0.0034	0.0302	CbGeAlD
Thioridazine—HTR7—vein—brain cancer	0.00331	0.0294	CbGeAlD
Thioridazine—Hepatotoxicity—Lomustine—brain cancer	0.00296	0.0364	CcSEcCtD
Thioridazine—HTR6—ganglion—brain cancer	0.00284	0.0253	CbGeAlD
Thioridazine—HTR2C—telencephalic ventricle—brain cancer	0.00264	0.0235	CbGeAlD
Thioridazine—HTR7—cranial nerve—brain cancer	0.00261	0.0232	CbGeAlD
Thioridazine—HTR7—pons—brain cancer	0.00258	0.0229	CbGeAlD
Thioridazine—HTR2A—trigeminal nerve—brain cancer	0.00228	0.0203	CbGeAlD
Thioridazine—HTR2A—cerebellar cortex—brain cancer	0.00228	0.0202	CbGeAlD
Thioridazine—HTR1A—telencephalic ventricle—brain cancer	0.00222	0.0197	CbGeAlD
Thioridazine—HTR7—telencephalic ventricle—brain cancer	0.00212	0.0189	CbGeAlD
Thioridazine—DRD1—ganglion—brain cancer	0.00211	0.0188	CbGeAlD
Thioridazine—HTR2A—vein—brain cancer	0.00206	0.0184	CbGeAlD
Thioridazine—Systemic lupus erythematosus—Hydroxyurea—brain cancer	0.00203	0.025	CcSEcCtD
Thioridazine—DRD2—telencephalic ventricle—brain cancer	0.00201	0.0178	CbGeAlD
Thioridazine—Trifluoperazine—S100A4—brain cancer	0.00197	0.582	CrCbGaD
Thioridazine—Eruption—Hydroxyurea—brain cancer	0.00182	0.0225	CcSEcCtD
Thioridazine—Lethargy—Lomustine—brain cancer	0.00169	0.0208	CcSEcCtD
Thioridazine—Amenorrhoea—Procarbazine—brain cancer	0.00165	0.0203	CcSEcCtD
Thioridazine—HTR2C—ganglion—brain cancer	0.00164	0.0146	CbGeAlD
Thioridazine—HTR2A—cranial nerve—brain cancer	0.00163	0.0145	CbGeAlD
Thioridazine—HTR2A—pons—brain cancer	0.00161	0.0143	CbGeAlD
Thioridazine—Hepatotoxicity—Hydroxyurea—brain cancer	0.00145	0.0179	CcSEcCtD
Thioridazine—HTR1A—ganglion—brain cancer	0.00138	0.0123	CbGeAlD
Thioridazine—Pancytopenia—Lomustine—brain cancer	0.00136	0.0168	CcSEcCtD
Thioridazine—HTR2A—telencephalic ventricle—brain cancer	0.00132	0.0118	CbGeAlD
Thioridazine—HTR7—ganglion—brain cancer	0.00132	0.0117	CbGeAlD
Thioridazine—Gynaecomastia—Procarbazine—brain cancer	0.0013	0.016	CcSEcCtD
Thioridazine—Amenorrhoea—Hydroxyurea—brain cancer	0.00128	0.0157	CcSEcCtD
Thioridazine—DRD2—ganglion—brain cancer	0.00125	0.0111	CbGeAlD
Thioridazine—Photosensitivity—Procarbazine—brain cancer	0.0012	0.0148	CcSEcCtD
Thioridazine—Hepatotoxicity—Carmustine—brain cancer	0.00117	0.0145	CcSEcCtD
Thioridazine—Extrapyramidal disorder—Temozolomide—brain cancer	0.00116	0.0143	CcSEcCtD
Thioridazine—Cholestasis—Temozolomide—brain cancer	0.00115	0.0142	CcSEcCtD
Thioridazine—HTR2A—pineal body—brain cancer	0.00115	0.0102	CbGeAlD
Thioridazine—HTR7—endothelium—brain cancer	0.00114	0.0101	CbGeAlD
Thioridazine—Hepatotoxicity—Temozolomide—brain cancer	0.00114	0.014	CcSEcCtD
Thioridazine—HTR6—telencephalon—brain cancer	0.0011	0.00975	CbGeAlD
Thioridazine—Lethargy—Procarbazine—brain cancer	0.00107	0.0132	CcSEcCtD
Thioridazine—HTR7—blood vessel—brain cancer	0.00105	0.00934	CbGeAlD
Thioridazine—HTR1A—hindbrain—brain cancer	0.00105	0.00932	CbGeAlD
Thioridazine—HTR7—hindbrain—brain cancer	0.001	0.00891	CbGeAlD
Thioridazine—Amenorrhoea—Temozolomide—brain cancer	0.000998	0.0123	CcSEcCtD
Thioridazine—ADRA1A—hindbrain—brain cancer	0.000966	0.00859	CbGeAlD
Thioridazine—DRD2—hindbrain—brain cancer	0.000947	0.00842	CbGeAlD
Thioridazine—DRD1—brainstem—brain cancer	0.000919	0.00817	CbGeAlD
Thioridazine—Hepatotoxicity—Etoposide—brain cancer	0.000908	0.0112	CcSEcCtD
Thioridazine—Eosinophilia—Procarbazine—brain cancer	0.000901	0.0111	CcSEcCtD
Thioridazine—Leukopenia—Lomustine—brain cancer	0.000894	0.011	CcSEcCtD
Thioridazine—Sweating increased—Procarbazine—brain cancer	0.000886	0.0109	CcSEcCtD
Thioridazine—Pancytopenia—Procarbazine—brain cancer	0.000864	0.0106	CcSEcCtD
Thioridazine—Photosensitivity reaction—Procarbazine—brain cancer	0.00083	0.0102	CcSEcCtD
Thioridazine—HTR2A—ganglion—brain cancer	0.000824	0.00733	CbGeAlD
Thioridazine—Aplastic anaemia—Temozolomide—brain cancer	0.000823	0.0101	CcSEcCtD
Thioridazine—DRD1—telencephalon—brain cancer	0.000816	0.00725	CbGeAlD
Thioridazine—Gynaecomastia—Carmustine—brain cancer	0.000812	0.01	CcSEcCtD
Thioridazine—Drowsiness—Procarbazine—brain cancer	0.000811	0.00999	CcSEcCtD
Thioridazine—Thrombocytopenia—Lomustine—brain cancer	0.000798	0.00983	CcSEcCtD
Thioridazine—Jaundice—Procarbazine—brain cancer	0.000791	0.00974	CcSEcCtD
Thioridazine—Anorexia—Lomustine—brain cancer	0.000777	0.00957	CcSEcCtD
Thioridazine—Body temperature increased—Carboplatin—brain cancer	0.000736	0.00907	CcSEcCtD
Thioridazine—HTR2C—brainstem—brain cancer	0.000714	0.00635	CbGeAlD
Thioridazine—HTR2A—endothelium—brain cancer	0.00071	0.00632	CbGeAlD
Thioridazine—Decreased appetite—Lomustine—brain cancer	0.000708	0.00873	CcSEcCtD
Thioridazine—Nasal congestion—Temozolomide—brain cancer	0.000699	0.00861	CcSEcCtD
Thioridazine—HTR6—head—brain cancer	0.000683	0.00607	CbGeAlD
Thioridazine—Dermatitis exfoliative—Temozolomide—brain cancer	0.000674	0.00831	CcSEcCtD
Thioridazine—Pancytopenia—Hydroxyurea—brain cancer	0.000669	0.00824	CcSEcCtD
Thioridazine—CHRM2—telencephalon—brain cancer	0.000657	0.00584	CbGeAlD
Thioridazine—HTR2A—blood vessel—brain cancer	0.000655	0.00583	CbGeAlD
Thioridazine—Arrhythmia—Procarbazine—brain cancer	0.00065	0.00801	CcSEcCtD
Thioridazine—Body temperature increased—Lomustine—brain cancer	0.000644	0.00794	CcSEcCtD
Thioridazine—Weight increased—Hydroxyurea—brain cancer	0.000641	0.00789	CcSEcCtD
Thioridazine—HTR2C—telencephalon—brain cancer	0.000634	0.00563	CbGeAlD
Thioridazine—Drowsiness—Hydroxyurea—brain cancer	0.000628	0.00773	CcSEcCtD
Thioridazine—HTR2A—hindbrain—brain cancer	0.000625	0.00556	CbGeAlD
Thioridazine—HTR6—central nervous system—brain cancer	0.000623	0.00554	CbGeAlD
Thioridazine—Eletriptan—CYP2C9—brain cancer	0.000602	0.178	CrCbGaD
Thioridazine—HTR1A—brainstem—brain cancer	0.000601	0.00534	CbGeAlD
Thioridazine—Tremor—Procarbazine—brain cancer	0.000594	0.00732	CcSEcCtD
Thioridazine—Anaemia—Procarbazine—brain cancer	0.000586	0.00722	CcSEcCtD
Thioridazine—DRD1—midbrain—brain cancer	0.000586	0.00521	CbGeAlD
Thioridazine—HTR7—brainstem—brain cancer	0.000574	0.00511	CbGeAlD
Thioridazine—CYP2D6—hindbrain—brain cancer	0.000569	0.00506	CbGeAlD
Thioridazine—Leukopenia—Procarbazine—brain cancer	0.000567	0.00699	CcSEcCtD
Thioridazine—ADRA1A—brainstem—brain cancer	0.000554	0.00493	CbGeAlD
Thioridazine—ADRA1B—head—brain cancer	0.000545	0.00484	CbGeAlD
Thioridazine—DRD2—brainstem—brain cancer	0.000543	0.00483	CbGeAlD
Thioridazine—Pancytopenia—Carmustine—brain cancer	0.000541	0.00666	CcSEcCtD
Thioridazine—Sweating increased—Temozolomide—brain cancer	0.000536	0.0066	CcSEcCtD
Thioridazine—HTR1A—telencephalon—brain cancer	0.000533	0.00474	CbGeAlD
Thioridazine—Pancytopenia—Temozolomide—brain cancer	0.000522	0.00644	CcSEcCtD
Thioridazine—Confusional state—Procarbazine—brain cancer	0.000522	0.00643	CcSEcCtD
Thioridazine—Vomiting—Lomustine—brain cancer	0.000518	0.00638	CcSEcCtD
Thioridazine—Oedema—Procarbazine—brain cancer	0.000517	0.00637	CcSEcCtD
Thioridazine—HTR7—telencephalon—brain cancer	0.00051	0.00453	CbGeAlD
Thioridazine—DRD1—head—brain cancer	0.000508	0.00452	CbGeAlD
Thioridazine—Thrombocytopenia—Procarbazine—brain cancer	0.000507	0.00624	CcSEcCtD
Thioridazine—Tachycardia—Procarbazine—brain cancer	0.000505	0.00622	CcSEcCtD
Thioridazine—Photosensitivity reaction—Temozolomide—brain cancer	0.000502	0.00619	CcSEcCtD
Thioridazine—Weight increased—Temozolomide—brain cancer	0.000501	0.00617	CcSEcCtD
Thioridazine—Hyperhidrosis—Procarbazine—brain cancer	0.0005	0.00616	CcSEcCtD
Thioridazine—HTR2C—medulla oblongata—brain cancer	0.000498	0.00443	CbGeAlD
Thioridazine—ADRA1B—central nervous system—brain cancer	0.000497	0.00442	CbGeAlD
Thioridazine—HTR6—brain—brain cancer	0.000495	0.0044	CbGeAlD
Thioridazine—Anorexia—Procarbazine—brain cancer	0.000493	0.00608	CcSEcCtD
Thioridazine—ADRA1A—telencephalon—brain cancer	0.000492	0.00437	CbGeAlD
Thioridazine—Erythema—Hydroxyurea—brain cancer	0.000491	0.00604	CcSEcCtD
Thioridazine—Cardiac arrest—Etoposide—brain cancer	0.000484	0.00597	CcSEcCtD
Thioridazine—Nausea—Lomustine—brain cancer	0.000484	0.00596	CcSEcCtD
Thioridazine—Hypotension—Procarbazine—brain cancer	0.000483	0.00596	CcSEcCtD
Thioridazine—DRD2—telencephalon—brain cancer	0.000482	0.00428	CbGeAlD
Thioridazine—KCNH2—telencephalon—brain cancer	0.000475	0.00422	CbGeAlD
Thioridazine—DRD1—central nervous system—brain cancer	0.000464	0.00412	CbGeAlD
Thioridazine—Somnolence—Procarbazine—brain cancer	0.00046	0.00567	CcSEcCtD
Thioridazine—HTR2C—midbrain—brain cancer	0.000455	0.00405	CbGeAlD
Thioridazine—Anaemia—Hydroxyurea—brain cancer	0.000453	0.00559	CcSEcCtD
Thioridazine—Decreased appetite—Procarbazine—brain cancer	0.00045	0.00554	CcSEcCtD
Thioridazine—Oedema peripheral—Carmustine—brain cancer	0.000449	0.00553	CcSEcCtD
Thioridazine—HTR2C—spinal cord—brain cancer	0.000444	0.00395	CbGeAlD
Thioridazine—Constipation—Procarbazine—brain cancer	0.000442	0.00545	CcSEcCtD
Thioridazine—Leukopenia—Hydroxyurea—brain cancer	0.000439	0.00541	CcSEcCtD
Thioridazine—Oedema peripheral—Temozolomide—brain cancer	0.000434	0.00534	CcSEcCtD
Thioridazine—Sweating increased—Etoposide—brain cancer	0.000429	0.00528	CcSEcCtD
Thioridazine—Feeling abnormal—Procarbazine—brain cancer	0.000426	0.00525	CcSEcCtD
Thioridazine—HTR7—gonad—brain cancer	0.000425	0.00378	CbGeAlD
Thioridazine—Pancytopenia—Etoposide—brain cancer	0.000418	0.00515	CcSEcCtD
Thioridazine—CHRM2—endocrine gland—brain cancer	0.000415	0.00369	CbGeAlD
Thioridazine—CHRM2—head—brain cancer	0.000409	0.00364	CbGeAlD
Thioridazine—Body temperature increased—Procarbazine—brain cancer	0.000409	0.00504	CcSEcCtD
Thioridazine—Arrhythmia—Carmustine—brain cancer	0.000407	0.00501	CcSEcCtD
Thioridazine—HTR7—medulla oblongata—brain cancer	0.0004	0.00356	CbGeAlD
Thioridazine—Oedema—Hydroxyurea—brain cancer	0.0004	0.00493	CcSEcCtD
Thioridazine—Mental disorder—Carmustine—brain cancer	0.000399	0.00492	CcSEcCtD
Thioridazine—Erythema—Carmustine—brain cancer	0.000397	0.00489	CcSEcCtD
Thioridazine—ADRA1B—brain—brain cancer	0.000395	0.00351	CbGeAlD
Thioridazine—HTR2C—head—brain cancer	0.000394	0.00351	CbGeAlD
Thioridazine—DRD2—pituitary gland—brain cancer	0.000392	0.00349	CbGeAlD
Thioridazine—Thrombocytopenia—Hydroxyurea—brain cancer	0.000392	0.00483	CcSEcCtD
Thioridazine—KCNH2—pituitary gland—brain cancer	0.000387	0.00344	CbGeAlD
Thioridazine—Mental disorder—Temozolomide—brain cancer	0.000386	0.00475	CcSEcCtD
Thioridazine—Erythema—Temozolomide—brain cancer	0.000383	0.00472	CcSEcCtD
Thioridazine—HTR1A—midbrain—brain cancer	0.000383	0.00341	CbGeAlD
Thioridazine—Jaundice—Etoposide—brain cancer	0.000383	0.00471	CcSEcCtD
Thioridazine—Anorexia—Hydroxyurea—brain cancer	0.000382	0.0047	CcSEcCtD
Thioridazine—Hypersensitivity—Procarbazine—brain cancer	0.000381	0.0047	CcSEcCtD
Thioridazine—HRH1—telencephalon—brain cancer	0.000381	0.00338	CbGeAlD
Thioridazine—ADRA2A—telencephalon—brain cancer	0.000374	0.00332	CbGeAlD
Thioridazine—Vision blurred—Carmustine—brain cancer	0.000374	0.0046	CcSEcCtD
Thioridazine—HTR1A—spinal cord—brain cancer	0.000374	0.00332	CbGeAlD
Thioridazine—CHRM2—central nervous system—brain cancer	0.000374	0.00332	CbGeAlD
Thioridazine—KCNH2—medulla oblongata—brain cancer	0.000373	0.00332	CbGeAlD
Thioridazine—Tremor—Carmustine—brain cancer	0.000372	0.00458	CcSEcCtD
Thioridazine—DRD1—brain—brain cancer	0.000368	0.00327	CbGeAlD
Thioridazine—Anaemia—Carmustine—brain cancer	0.000367	0.00452	CcSEcCtD
Thioridazine—Agranulocytosis—Etoposide—brain cancer	0.000366	0.00451	CcSEcCtD
Thioridazine—HTR7—midbrain—brain cancer	0.000366	0.00325	CbGeAlD
Thioridazine—CYP2E1—telencephalon—brain cancer	0.000366	0.00325	CbGeAlD
Thioridazine—Agitation—Carmustine—brain cancer	0.000364	0.00449	CcSEcCtD
Thioridazine—Vision blurred—Temozolomide—brain cancer	0.000361	0.00445	CcSEcCtD
Thioridazine—HTR2C—central nervous system—brain cancer	0.00036	0.0032	CbGeAlD
Thioridazine—Tremor—Temozolomide—brain cancer	0.000359	0.00442	CcSEcCtD
Thioridazine—HTR2A—brainstem—brain cancer	0.000358	0.00318	CbGeAlD
Thioridazine—HTR7—spinal cord—brain cancer	0.000357	0.00318	CbGeAlD
Thioridazine—Somnolence—Hydroxyurea—brain cancer	0.000356	0.00439	CcSEcCtD
Thioridazine—Leukopenia—Carmustine—brain cancer	0.000355	0.00437	CcSEcCtD
Thioridazine—Anaemia—Temozolomide—brain cancer	0.000354	0.00436	CcSEcCtD
Thioridazine—Diarrhoea—Procarbazine—brain cancer	0.000354	0.00436	CcSEcCtD
Thioridazine—CYP2C8—pituitary gland—brain cancer	0.000354	0.00314	CbGeAlD
Thioridazine—Agitation—Temozolomide—brain cancer	0.000352	0.00434	CcSEcCtD
Thioridazine—Angioedema—Temozolomide—brain cancer	0.00035	0.00431	CcSEcCtD
Thioridazine—Decreased appetite—Hydroxyurea—brain cancer	0.000348	0.00429	CcSEcCtD
Thioridazine—DRD2—midbrain—brain cancer	0.000346	0.00308	CbGeAlD
Thioridazine—Leukopenia—Temozolomide—brain cancer	0.000343	0.00423	CcSEcCtD
Thioridazine—Constipation—Hydroxyurea—brain cancer	0.000342	0.00422	CcSEcCtD
Thioridazine—KCNH2—midbrain—brain cancer	0.000341	0.00303	CbGeAlD
Thioridazine—HTR1A—endocrine gland—brain cancer	0.000336	0.00299	CbGeAlD
Thioridazine—KCNH2—spinal cord—brain cancer	0.000333	0.00296	CbGeAlD
Thioridazine—HTR1A—head—brain cancer	0.000332	0.00295	CbGeAlD
Thioridazine—Feeling abnormal—Hydroxyurea—brain cancer	0.00033	0.00407	CcSEcCtD
Thioridazine—Vomiting—Procarbazine—brain cancer	0.000329	0.00405	CcSEcCtD
Thioridazine—Confusional state—Carmustine—brain cancer	0.000326	0.00402	CcSEcCtD
Thioridazine—CYP2D6—brainstem—brain cancer	0.000326	0.0029	CbGeAlD
Thioridazine—Rash—Procarbazine—brain cancer	0.000326	0.00402	CcSEcCtD
Thioridazine—Dermatitis—Procarbazine—brain cancer	0.000326	0.00402	CcSEcCtD
Thioridazine—Headache—Procarbazine—brain cancer	0.000324	0.00399	CcSEcCtD
Thioridazine—Oedema—Carmustine—brain cancer	0.000324	0.00399	CcSEcCtD
Thioridazine—HTR7—endocrine gland—brain cancer	0.000321	0.00286	CbGeAlD
Thioridazine—HTR2A—telencephalon—brain cancer	0.000318	0.00283	CbGeAlD
Thioridazine—HTR7—head—brain cancer	0.000317	0.00282	CbGeAlD
Thioridazine—Thrombocytopenia—Carmustine—brain cancer	0.000317	0.0039	CcSEcCtD
Thioridazine—Body temperature increased—Hydroxyurea—brain cancer	0.000316	0.0039	CcSEcCtD
Thioridazine—Tachycardia—Carmustine—brain cancer	0.000316	0.00389	CcSEcCtD
Thioridazine—Confusional state—Temozolomide—brain cancer	0.000315	0.00389	CcSEcCtD
Thioridazine—CYP2C19—endocrine gland—brain cancer	0.000314	0.00279	CbGeAlD
Thioridazine—Oedema—Temozolomide—brain cancer	0.000313	0.00385	CcSEcCtD
Thioridazine—ADRA2A—gonad—brain cancer	0.000312	0.00277	CbGeAlD
Thioridazine—ADRA1A—endocrine gland—brain cancer	0.00031	0.00276	CbGeAlD
Thioridazine—Anorexia—Carmustine—brain cancer	0.000309	0.0038	CcSEcCtD
Thioridazine—Nausea—Procarbazine—brain cancer	0.000307	0.00379	CcSEcCtD
Thioridazine—Thrombocytopenia—Temozolomide—brain cancer	0.000306	0.00377	CcSEcCtD
Thioridazine—ADRA1A—head—brain cancer	0.000306	0.00272	CbGeAlD
Thioridazine—ADRA2A—pituitary gland—brain cancer	0.000304	0.00271	CbGeAlD
Thioridazine—DRD2—endocrine gland—brain cancer	0.000304	0.0027	CbGeAlD
Thioridazine—HTR1A—central nervous system—brain cancer	0.000303	0.0027	CbGeAlD
Thioridazine—Hypotension—Carmustine—brain cancer	0.000302	0.00373	CcSEcCtD
Thioridazine—Hyperhidrosis—Temozolomide—brain cancer	0.000302	0.00373	CcSEcCtD
Thioridazine—DRD2—head—brain cancer	0.0003	0.00267	CbGeAlD
Thioridazine—KCNH2—endocrine gland—brain cancer	0.000299	0.00266	CbGeAlD
Thioridazine—Anorexia—Temozolomide—brain cancer	0.000298	0.00367	CcSEcCtD
Thioridazine—CHRM2—brain—brain cancer	0.000297	0.00264	CbGeAlD
Thioridazine—HTR1A—cerebellum—brain cancer	0.000296	0.00263	CbGeAlD
Thioridazine—KCNH2—head—brain cancer	0.000296	0.00263	CbGeAlD
Thioridazine—Hypersensitivity—Hydroxyurea—brain cancer	0.000295	0.00363	CcSEcCtD
Thioridazine—ADRA2A—medulla oblongata—brain cancer	0.000294	0.00261	CbGeAlD
Thioridazine—HTR7—central nervous system—brain cancer	0.00029	0.00258	CbGeAlD
Thioridazine—CYP2D6—telencephalon—brain cancer	0.00029	0.00257	CbGeAlD
Thioridazine—Somnolence—Carmustine—brain cancer	0.000288	0.00355	CcSEcCtD
Thioridazine—CYP2E1—medulla oblongata—brain cancer	0.000287	0.00255	CbGeAlD
Thioridazine—HTR2C—brain—brain cancer	0.000286	0.00254	CbGeAlD
Thioridazine—Promethazine—CYP2C9—brain cancer	0.000284	0.084	CrCbGaD
Thioridazine—Anaemia—Etoposide—brain cancer	0.000283	0.00349	CcSEcCtD
Thioridazine—HTR7—cerebellum—brain cancer	0.000283	0.00252	CbGeAlD
Thioridazine—Decreased appetite—Carmustine—brain cancer	0.000281	0.00347	CcSEcCtD
Thioridazine—ADRA1A—central nervous system—brain cancer	0.000279	0.00248	CbGeAlD
Thioridazine—Somnolence—Temozolomide—brain cancer	0.000278	0.00343	CcSEcCtD
Thioridazine—Perphenazine—CYP2C9—brain cancer	0.000277	0.0819	CrCbGaD
Thioridazine—Constipation—Carmustine—brain cancer	0.000277	0.00341	CcSEcCtD
Thioridazine—Leukopenia—Etoposide—brain cancer	0.000275	0.00338	CcSEcCtD
Thioridazine—CYP2C8—endocrine gland—brain cancer	0.000274	0.00244	CbGeAlD
Thioridazine—Diarrhoea—Hydroxyurea—brain cancer	0.000274	0.00338	CcSEcCtD
Thioridazine—DRD2—central nervous system—brain cancer	0.000274	0.00244	CbGeAlD
Thioridazine—ADRA1A—cerebellum—brain cancer	0.000273	0.00243	CbGeAlD
Thioridazine—Decreased appetite—Temozolomide—brain cancer	0.000272	0.00335	CcSEcCtD
Thioridazine—KCNH2—central nervous system—brain cancer	0.00027	0.0024	CbGeAlD
Thioridazine—ADRA2A—midbrain—brain cancer	0.000268	0.00239	CbGeAlD
Thioridazine—DRD2—cerebellum—brain cancer	0.000268	0.00238	CbGeAlD
Thioridazine—Constipation—Temozolomide—brain cancer	0.000267	0.0033	CcSEcCtD
Thioridazine—Feeling abnormal—Carmustine—brain cancer	0.000267	0.00329	CcSEcCtD
Thioridazine—HTR2A—gonad—brain cancer	0.000265	0.00236	CbGeAlD
Thioridazine—KCNH2—cerebellum—brain cancer	0.000264	0.00235	CbGeAlD
Thioridazine—ADRA2A—spinal cord—brain cancer	0.000262	0.00233	CbGeAlD
Thioridazine—HTR2A—pituitary gland—brain cancer	0.000259	0.0023	CbGeAlD
Thioridazine—Feeling abnormal—Temozolomide—brain cancer	0.000258	0.00318	CcSEcCtD
Thioridazine—CYP1A2—endocrine gland—brain cancer	0.000256	0.00228	CbGeAlD
Thioridazine—CYP2E1—spinal cord—brain cancer	0.000256	0.00228	CbGeAlD
Thioridazine—Body temperature increased—Carmustine—brain cancer	0.000256	0.00315	CcSEcCtD
Thioridazine—Vomiting—Hydroxyurea—brain cancer	0.000255	0.00314	CcSEcCtD
Thioridazine—Rash—Hydroxyurea—brain cancer	0.000252	0.00311	CcSEcCtD
Thioridazine—Confusional state—Etoposide—brain cancer	0.000252	0.00311	CcSEcCtD
Thioridazine—Dermatitis—Hydroxyurea—brain cancer	0.000252	0.00311	CcSEcCtD
Thioridazine—Headache—Hydroxyurea—brain cancer	0.000251	0.00309	CcSEcCtD
Thioridazine—Promazine—CYP2C9—brain cancer	0.00025	0.0739	CrCbGaD
Thioridazine—HTR2A—medulla oblongata—brain cancer	0.00025	0.00222	CbGeAlD
Thioridazine—Body temperature increased—Temozolomide—brain cancer	0.000247	0.00305	CcSEcCtD
Thioridazine—Thrombocytopenia—Etoposide—brain cancer	0.000245	0.00302	CcSEcCtD
Thioridazine—Tachycardia—Etoposide—brain cancer	0.000244	0.00301	CcSEcCtD
Thioridazine—CYP2C9—endocrine gland—brain cancer	0.000243	0.00216	CbGeAlD
Thioridazine—Hyperhidrosis—Etoposide—brain cancer	0.000242	0.00298	CcSEcCtD
Thioridazine—HTR1A—brain—brain cancer	0.000241	0.00214	CbGeAlD
Thioridazine—HRH1—endocrine gland—brain cancer	0.00024	0.00213	CbGeAlD
Thioridazine—Anorexia—Etoposide—brain cancer	0.000239	0.00294	CcSEcCtD
Thioridazine—Hypersensitivity—Carmustine—brain cancer	0.000238	0.00294	CcSEcCtD
Thioridazine—Nausea—Hydroxyurea—brain cancer	0.000238	0.00293	CcSEcCtD
Thioridazine—HRH1—head—brain cancer	0.000237	0.00211	CbGeAlD
Thioridazine—ADRA2A—endocrine gland—brain cancer	0.000236	0.0021	CbGeAlD
Thioridazine—Hypotension—Etoposide—brain cancer	0.000234	0.00288	CcSEcCtD
Thioridazine—ADRA2A—head—brain cancer	0.000233	0.00207	CbGeAlD
Thioridazine—CYP2E1—endocrine gland—brain cancer	0.000231	0.00205	CbGeAlD
Thioridazine—Hypersensitivity—Temozolomide—brain cancer	0.00023	0.00284	CcSEcCtD
Thioridazine—HTR7—brain—brain cancer	0.00023	0.00204	CbGeAlD
Thioridazine—HTR2A—midbrain—brain cancer	0.000228	0.00203	CbGeAlD
Thioridazine—CYP2E1—head—brain cancer	0.000228	0.00202	CbGeAlD
Thioridazine—HTR2A—spinal cord—brain cancer	0.000223	0.00198	CbGeAlD
Thioridazine—Somnolence—Etoposide—brain cancer	0.000222	0.00274	CcSEcCtD
Thioridazine—ADRA1A—brain—brain cancer	0.000222	0.00197	CbGeAlD
Thioridazine—Diarrhoea—Carmustine—brain cancer	0.000221	0.00273	CcSEcCtD
Thioridazine—Decreased appetite—Etoposide—brain cancer	0.000218	0.00268	CcSEcCtD
Thioridazine—DRD2—brain—brain cancer	0.000217	0.00193	CbGeAlD
Thioridazine—HRH1—central nervous system—brain cancer	0.000216	0.00192	CbGeAlD
Thioridazine—KCNH2—brain—brain cancer	0.000214	0.00191	CbGeAlD
Thioridazine—Constipation—Etoposide—brain cancer	0.000214	0.00264	CcSEcCtD
Thioridazine—Diarrhoea—Temozolomide—brain cancer	0.000214	0.00264	CcSEcCtD
Thioridazine—ADRA2A—central nervous system—brain cancer	0.000212	0.00189	CbGeAlD
Thioridazine—CYP2E1—central nervous system—brain cancer	0.000208	0.00185	CbGeAlD
Thioridazine—ADRA2A—cerebellum—brain cancer	0.000208	0.00185	CbGeAlD
Thioridazine—Feeling abnormal—Etoposide—brain cancer	0.000206	0.00254	CcSEcCtD
Thioridazine—Vomiting—Carmustine—brain cancer	0.000206	0.00254	CcSEcCtD
Thioridazine—Rash—Carmustine—brain cancer	0.000204	0.00251	CcSEcCtD
Thioridazine—Dermatitis—Carmustine—brain cancer	0.000204	0.00251	CcSEcCtD
Thioridazine—CYP2E1—cerebellum—brain cancer	0.000203	0.00181	CbGeAlD
Thioridazine—Headache—Carmustine—brain cancer	0.000203	0.0025	CcSEcCtD
Thioridazine—HTR2A—endocrine gland—brain cancer	0.0002	0.00178	CbGeAlD
Thioridazine—Vomiting—Temozolomide—brain cancer	0.000199	0.00245	CcSEcCtD
Thioridazine—HTR2A—head—brain cancer	0.000198	0.00176	CbGeAlD
Thioridazine—Body temperature increased—Etoposide—brain cancer	0.000198	0.00244	CcSEcCtD
Thioridazine—Rash—Temozolomide—brain cancer	0.000197	0.00243	CcSEcCtD
Thioridazine—Dermatitis—Temozolomide—brain cancer	0.000197	0.00243	CcSEcCtD
Thioridazine—CYP2C8—brain—brain cancer	0.000196	0.00174	CbGeAlD
Thioridazine—Headache—Temozolomide—brain cancer	0.000196	0.00241	CcSEcCtD
Thioridazine—Nausea—Carmustine—brain cancer	0.000192	0.00237	CcSEcCtD
Thioridazine—Nausea—Temozolomide—brain cancer	0.000186	0.00229	CcSEcCtD
Thioridazine—Hypersensitivity—Etoposide—brain cancer	0.000184	0.00227	CcSEcCtD
Thioridazine—CYP2D6—endocrine gland—brain cancer	0.000183	0.00162	CbGeAlD
Thioridazine—HTR2A—central nervous system—brain cancer	0.000181	0.00161	CbGeAlD
Thioridazine—CYP2D6—head—brain cancer	0.00018	0.0016	CbGeAlD
Thioridazine—HTR2A—cerebellum—brain cancer	0.000177	0.00157	CbGeAlD
Thioridazine—HRH1—brain—brain cancer	0.000172	0.00153	CbGeAlD
Thioridazine—Diarrhoea—Etoposide—brain cancer	0.000171	0.00211	CcSEcCtD
Thioridazine—ADRA2A—brain—brain cancer	0.000169	0.0015	CbGeAlD
Thioridazine—CYP2E1—brain—brain cancer	0.000165	0.00147	CbGeAlD
Thioridazine—CYP2D6—central nervous system—brain cancer	0.000165	0.00146	CbGeAlD
Thioridazine—CYP2D6—cerebellum—brain cancer	0.000161	0.00143	CbGeAlD
Thioridazine—Vomiting—Etoposide—brain cancer	0.000159	0.00196	CcSEcCtD
Thioridazine—Rash—Etoposide—brain cancer	0.000158	0.00194	CcSEcCtD
Thioridazine—Dermatitis—Etoposide—brain cancer	0.000158	0.00194	CcSEcCtD
Thioridazine—Headache—Etoposide—brain cancer	0.000157	0.00193	CcSEcCtD
Thioridazine—Nausea—Etoposide—brain cancer	0.000149	0.00183	CcSEcCtD
Thioridazine—HTR2A—brain—brain cancer	0.000143	0.00128	CbGeAlD
Thioridazine—CYP2D6—brain—brain cancer	0.000131	0.00116	CbGeAlD
Thioridazine—DRD1—Signaling Pathways—PDGFRA—brain cancer	1.17e-05	0.000196	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.16e-05	0.000195	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—PIK3CG—brain cancer	1.16e-05	0.000194	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—PIK3CG—brain cancer	1.14e-05	0.000191	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—PIK3CG—brain cancer	1.14e-05	0.000191	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—PIK3CG—brain cancer	1.14e-05	0.00019	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—SPP1—brain cancer	1.13e-05	0.00019	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—ENO2—brain cancer	1.13e-05	0.000189	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—NOTCH2—brain cancer	1.13e-05	0.000189	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—PIK3CG—brain cancer	1.12e-05	0.000187	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—PIK3CG—brain cancer	1.11e-05	0.000187	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—IDH1—brain cancer	1.11e-05	0.000187	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—NOTCH2—brain cancer	1.11e-05	0.000186	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—NOTCH2—brain cancer	1.11e-05	0.000186	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—NOTCH2—brain cancer	1.09e-05	0.000183	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—NOTCH2—brain cancer	1.09e-05	0.000182	CbGpPWpGaD
Thioridazine—ADRA2A—Hemostasis—VEGFA—brain cancer	1.08e-05	0.000181	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—IL2—brain cancer	1.08e-05	0.000181	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—VAV1—brain cancer	1.08e-05	0.00018	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.06e-05	0.000178	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—VAV1—brain cancer	1.06e-05	0.000177	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—VAV1—brain cancer	1.06e-05	0.000177	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—HES1—brain cancer	1.05e-05	0.000177	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—PIK3CG—brain cancer	1.05e-05	0.000176	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—APC—brain cancer	1.05e-05	0.000176	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—APC—brain cancer	1.05e-05	0.000176	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—PIK3CG—brain cancer	1.05e-05	0.000176	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—HES1—brain cancer	1.05e-05	0.000176	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—VAV1—brain cancer	1.04e-05	0.000174	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—ENO2—brain cancer	1.04e-05	0.000174	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—VAV1—brain cancer	1.04e-05	0.000174	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—PIK3CG—brain cancer	1.04e-05	0.000174	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—ENO2—brain cancer	1.03e-05	0.000173	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—IRS2—brain cancer	1.02e-05	0.000172	CbGpPWpGaD
Thioridazine—HTR1A—GPCR downstream signaling—IL2—brain cancer	1.02e-05	0.000171	CbGpPWpGaD
Thioridazine—HTR2C—GPCR downstream signaling—IL2—brain cancer	1.02e-05	0.00017	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—NOTCH2—brain cancer	1.01e-05	0.000169	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—HES1—brain cancer	1e-05	0.000168	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—PDGFRA—brain cancer	1e-05	0.000168	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—PDGFRA—brain cancer	9.98e-06	0.000167	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—SPP1—brain cancer	9.74e-06	0.000163	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR downstream signaling—IL2—brain cancer	9.72e-06	0.000163	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—SPP1—brain cancer	9.69e-06	0.000162	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—VAV1—brain cancer	9.63e-06	0.000161	CbGpPWpGaD
Thioridazine—HTR6—Signaling by GPCR—EGFR—brain cancer	9.58e-06	0.000161	CbGpPWpGaD
Thioridazine—HTR7—Signaling by GPCR—EGFR—brain cancer	9.57e-06	0.00016	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—PDGFRA—brain cancer	9.56e-06	0.00016	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—SPP1—brain cancer	9.28e-06	0.000156	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—IL2—brain cancer	9.27e-06	0.000155	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—HES1—brain cancer	9.25e-06	0.000155	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—IL2—brain cancer	9.22e-06	0.000155	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—HES1—brain cancer	9.1e-06	0.000153	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—HES1—brain cancer	9.08e-06	0.000152	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.06e-06	0.000152	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—APC—brain cancer	9.05e-06	0.000152	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—PIK3CG—brain cancer	9.05e-06	0.000152	CbGpPWpGaD
Thioridazine—DRD2—GPCR downstream signaling—IL2—brain cancer	8.96e-06	0.00015	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—HES1—brain cancer	8.94e-06	0.00015	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—HES1—brain cancer	8.91e-06	0.000149	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—IL2—brain cancer	8.83e-06	0.000148	CbGpPWpGaD
Thioridazine—HTR2A—GPCR downstream signaling—IL2—brain cancer	8.82e-06	0.000148	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—PDGFRA—brain cancer	8.81e-06	0.000148	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—IRS2—brain cancer	8.81e-06	0.000148	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—ENO2—brain cancer	8.8e-06	0.000148	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—IL2—brain cancer	8.8e-06	0.000148	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—IRS2—brain cancer	8.76e-06	0.000147	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—PDGFRA—brain cancer	8.67e-06	0.000145	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—IL2—brain cancer	8.66e-06	0.000145	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—PDGFRA—brain cancer	8.65e-06	0.000145	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—IL2—brain cancer	8.63e-06	0.000145	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—SPP1—brain cancer	8.55e-06	0.000143	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—PDGFRA—brain cancer	8.51e-06	0.000143	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—PDGFRA—brain cancer	8.49e-06	0.000142	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—SPP1—brain cancer	8.42e-06	0.000141	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—SPP1—brain cancer	8.4e-06	0.000141	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—IRS2—brain cancer	8.39e-06	0.000141	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—HES1—brain cancer	8.28e-06	0.000139	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—SPP1—brain cancer	8.26e-06	0.000139	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—EGFR—brain cancer	8.24e-06	0.000138	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—SPP1—brain cancer	8.24e-06	0.000138	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—RELA—brain cancer	8.21e-06	0.000138	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—RELA—brain cancer	8.2e-06	0.000138	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—ERBB2—brain cancer	8.16e-06	0.000137	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—ERBB2—brain cancer	8.15e-06	0.000137	CbGpPWpGaD
Thioridazine—ADRA2A—Hemostasis—TP53—brain cancer	8.15e-06	0.000137	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—IL2—brain cancer	8.14e-06	0.000136	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—IL2—brain cancer	8.02e-06	0.000134	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—IL2—brain cancer	8.01e-06	0.000134	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—IL2—brain cancer	7.99e-06	0.000134	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—PDGFRA—brain cancer	7.89e-06	0.000132	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—IL2—brain cancer	7.86e-06	0.000132	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—IL2—brain cancer	7.84e-06	0.000131	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—PIK3CG—brain cancer	7.78e-06	0.00013	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—APC—brain cancer	7.78e-06	0.00013	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—PIK3CG—brain cancer	7.74e-06	0.00013	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—APC—brain cancer	7.74e-06	0.00013	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—IRS2—brain cancer	7.73e-06	0.00013	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—SPP1—brain cancer	7.66e-06	0.000128	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—IRS2—brain cancer	7.61e-06	0.000128	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—IRS2—brain cancer	7.59e-06	0.000127	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—IRS2—brain cancer	7.47e-06	0.000125	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—IRS2—brain cancer	7.45e-06	0.000125	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—APC—brain cancer	7.41e-06	0.000124	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—PIK3CG—brain cancer	7.41e-06	0.000124	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—IL2—brain cancer	7.4e-06	0.000124	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—IL2—brain cancer	7.39e-06	0.000124	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—PIK3CG—brain cancer	7.31e-06	0.000123	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—IL2—brain cancer	7.28e-06	0.000122	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—CCND1—brain cancer	7.21e-06	0.000121	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—CCND1—brain cancer	7.2e-06	0.000121	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—CTNNB1—brain cancer	7.14e-06	0.00012	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—CTNNB1—brain cancer	7.13e-06	0.00012	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—EGFR—brain cancer	7.09e-06	0.000119	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—RELA—brain cancer	7.07e-06	0.000119	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—EGFR—brain cancer	7.05e-06	0.000118	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—ERBB2—brain cancer	7.03e-06	0.000118	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—IRS2—brain cancer	6.92e-06	0.000116	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—PIK3CG—brain cancer	6.83e-06	0.000115	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—APC—brain cancer	6.83e-06	0.000115	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—EGFR—brain cancer	6.75e-06	0.000113	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—APC—brain cancer	6.72e-06	0.000113	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—PIK3CG—brain cancer	6.72e-06	0.000113	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—PIK3CG—brain cancer	6.72e-06	0.000113	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—APC—brain cancer	6.71e-06	0.000112	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—PIK3CG—brain cancer	6.71e-06	0.000112	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—PIK3CG—brain cancer	6.6e-06	0.000111	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—APC—brain cancer	6.6e-06	0.000111	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—PIK3CG—brain cancer	6.58e-06	0.00011	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—APC—brain cancer	6.58e-06	0.00011	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—IL2—brain cancer	6.37e-06	0.000107	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—VEGFA—brain cancer	6.29e-06	0.000105	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—VEGFA—brain cancer	6.28e-06	0.000105	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—STAT3—brain cancer	6.22e-06	0.000104	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—EGFR—brain cancer	6.22e-06	0.000104	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—STAT3—brain cancer	6.22e-06	0.000104	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—CCND1—brain cancer	6.21e-06	0.000104	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—CTNNB1—brain cancer	6.15e-06	0.000103	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—EGFR—brain cancer	6.12e-06	0.000103	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—PIK3CG—brain cancer	6.12e-06	0.000103	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—APC—brain cancer	6.12e-06	0.000103	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—EGFR—brain cancer	6.11e-06	0.000102	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—RELA—brain cancer	6.08e-06	0.000102	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—RELA—brain cancer	6.05e-06	0.000101	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—ERBB2—brain cancer	6.04e-06	0.000101	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—EGFR—brain cancer	6.01e-06	0.000101	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—ERBB2—brain cancer	6.01e-06	0.000101	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—EGFR—brain cancer	6e-06	0.000101	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PIK3CG—brain cancer	5.8e-06	9.73e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—RELA—brain cancer	5.79e-06	9.71e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—MYC—brain cancer	5.78e-06	9.7e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—MYC—brain cancer	5.78e-06	9.69e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—ERBB2—brain cancer	5.75e-06	9.65e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—EGFR—brain cancer	5.66e-06	9.48e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—EGFR—brain cancer	5.65e-06	9.47e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—EGFR—brain cancer	5.57e-06	9.34e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—IL2—brain cancer	5.48e-06	9.18e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—IL2—brain cancer	5.45e-06	9.13e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—VEGFA—brain cancer	5.41e-06	9.07e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—STAT3—brain cancer	5.36e-06	8.98e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—RELA—brain cancer	5.34e-06	8.95e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—CCND1—brain cancer	5.34e-06	8.95e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—CCND1—brain cancer	5.31e-06	8.9e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—ERBB2—brain cancer	5.3e-06	8.89e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—CTNNB1—brain cancer	5.29e-06	8.86e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—CTNNB1—brain cancer	5.26e-06	8.82e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—RELA—brain cancer	5.25e-06	8.81e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—RELA—brain cancer	5.24e-06	8.79e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—ERBB2—brain cancer	5.22e-06	8.75e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—IL2—brain cancer	5.21e-06	8.74e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—ERBB2—brain cancer	5.21e-06	8.73e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PIK3CG—brain cancer	5.18e-06	8.69e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—RELA—brain cancer	5.16e-06	8.65e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—RELA—brain cancer	5.14e-06	8.62e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—ERBB2—brain cancer	5.12e-06	8.59e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—ERBB2—brain cancer	5.11e-06	8.57e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—CCND1—brain cancer	5.08e-06	8.52e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—CTNNB1—brain cancer	5.03e-06	8.44e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—MYC—brain cancer	4.98e-06	8.35e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—EGFR—brain cancer	4.87e-06	8.16e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—IL2—brain cancer	4.81e-06	8.06e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—RELA—brain cancer	4.78e-06	8.01e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PIK3CG—brain cancer	4.77e-06	7.99e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—TP53—brain cancer	4.75e-06	7.96e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—ERBB2—brain cancer	4.75e-06	7.96e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—TP53—brain cancer	4.74e-06	7.95e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—IL2—brain cancer	4.73e-06	7.93e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PIK3CG—brain cancer	4.72e-06	7.92e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—IL2—brain cancer	4.72e-06	7.91e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CCND1—brain cancer	4.69e-06	7.86e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—VEGFA—brain cancer	4.65e-06	7.8e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—IL2—brain cancer	4.64e-06	7.79e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CTNNB1—brain cancer	4.64e-06	7.78e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—IL2—brain cancer	4.63e-06	7.76e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—VEGFA—brain cancer	4.63e-06	7.76e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CCND1—brain cancer	4.61e-06	7.73e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—STAT3—brain cancer	4.61e-06	7.72e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CCND1—brain cancer	4.6e-06	7.71e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—STAT3—brain cancer	4.58e-06	7.68e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CTNNB1—brain cancer	4.57e-06	7.66e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CTNNB1—brain cancer	4.56e-06	7.64e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CCND1—brain cancer	4.53e-06	7.59e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CCND1—brain cancer	4.51e-06	7.57e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CTNNB1—brain cancer	4.48e-06	7.52e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CTNNB1—brain cancer	4.47e-06	7.5e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—VEGFA—brain cancer	4.43e-06	7.43e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—STAT3—brain cancer	4.39e-06	7.36e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—IL2—brain cancer	4.3e-06	7.21e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—MYC—brain cancer	4.28e-06	7.18e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—MYC—brain cancer	4.26e-06	7.14e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CCND1—brain cancer	4.19e-06	7.03e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—EGFR—brain cancer	4.19e-06	7.02e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—EGFR—brain cancer	4.17e-06	6.98e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CTNNB1—brain cancer	4.15e-06	6.96e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—TP53—brain cancer	4.09e-06	6.85e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—VEGFA—brain cancer	4.09e-06	6.85e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—MYC—brain cancer	4.08e-06	6.84e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—STAT3—brain cancer	4.05e-06	6.78e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PIK3CG—brain cancer	4.04e-06	6.77e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—VEGFA—brain cancer	4.02e-06	6.74e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—VEGFA—brain cancer	4.01e-06	6.72e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—EGFR—brain cancer	3.99e-06	6.69e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—STAT3—brain cancer	3.98e-06	6.67e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—STAT3—brain cancer	3.97e-06	6.66e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—VEGFA—brain cancer	3.95e-06	6.62e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—VEGFA—brain cancer	3.94e-06	6.6e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—STAT3—brain cancer	3.91e-06	6.55e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—STAT3—brain cancer	3.9e-06	6.53e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—MYC—brain cancer	3.76e-06	6.3e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—MYC—brain cancer	3.7e-06	6.2e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—MYC—brain cancer	3.69e-06	6.19e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—EGFR—brain cancer	3.68e-06	6.16e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—VEGFA—brain cancer	3.66e-06	6.13e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—MYC—brain cancer	3.63e-06	6.09e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—MYC—brain cancer	3.62e-06	6.07e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—STAT3—brain cancer	3.62e-06	6.07e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—EGFR—brain cancer	3.62e-06	6.06e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—EGFR—brain cancer	3.61e-06	6.05e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—EGFR—brain cancer	3.55e-06	5.95e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—EGFR—brain cancer	3.54e-06	5.94e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—TP53—brain cancer	3.52e-06	5.89e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—TP53—brain cancer	3.5e-06	5.86e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MYC—brain cancer	3.36e-06	5.64e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—TP53—brain cancer	3.35e-06	5.61e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—EGFR—brain cancer	3.29e-06	5.52e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—TP53—brain cancer	3.09e-06	5.18e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—TP53—brain cancer	3.04e-06	5.09e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—TP53—brain cancer	3.03e-06	5.08e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—TP53—brain cancer	2.98e-06	5e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—TP53—brain cancer	2.97e-06	4.99e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—TP53—brain cancer	2.76e-06	4.63e-05	CbGpPWpGaD
